Patients were subdivided into two groups: those with good and those with impaired graft functions. Patients Background. Persistent hyperparathyroidism after with good graft function had stable serum creatinine renal transplantation (Rtx) has been reported in several levels (∏132 mmol/l or ∏1.5 mg/dl ) well below the studies. However these studies evaluated biochemical mean serum creatinine concentration during the study bone parameters either only during a short time period period. The significant changes in AP, BAP, and OC (up to 6 months) or for a longer time period, but with occurred irrespective of renal function. However, long intervals in between. Therefore, we prospectively patients with impaired graft function (n=65) had evaluated biochemical bone parameters of kidneysignificantly higher PTH-levels (70 pg/ml higher) than transplant recipients at short intervals for 2 years patients with good graft function (n=64) Conclusion. Hypercalcaemia is a common phenomto 0.98±0.025 (12m), but remained within the lower enon in the early period after kidney transplantation normal range. We observed a rise in total and albumin and occurs in the presence of low normal phosphorus adjusted calcium concentrations 3 months after Rtx. levels. It is most probably related to improved PTH 52% of all patients had serum calcium levels above action and 1-hydroxylation of vitamin D. The rise in 2.62 mmol/l (upper normal limit in our laboratory) 3 biochemical bone parameters between 3 and 5 months months after renal transplantation with a gradual occurs irrespective of graft function and normalization decrease thereafter. There was no correlation of cal-is only achieved 1 year after transplantation. PTH is cium and PTH levels. We observed a significant rise in constantly elevated for up to 2 years after kidney biochemical bone parameters from 2 to 5 months after transplantation and is most probably related (a) to renal transplantation (P<0.001): alkaline phosphatase impaired graft function and (b) to suboptimal 25 OH (AP) increased from 164.3±9.4 to 236±12.7 U/l vitamin D supply. (normal 50-180), bone specific alkaline phosphatase (BAP) rose from 17.7±1.36 to 23.2±1.7 ng/ml Key words: hypercalcaemia; biochemical bone para-(normal:4-20) and osteocalcin (OC ) increased from meters; renal transplantation; secondary hyperparathy-20.2±1.5 to 26.7±1.9 ng/ml (normal 4-12). AP and roidism; vitamin D BAP levels values normalized 12 months after renal transplantation, whereas OC was still above normal throughout the study period.
regarding the time of its onset and resolution [4, [8] [9] [10] [11] [12] . as mean±s.e.m. Data were analysed by anlysis of variance (repeated-measurements ANOVA). Correlations between Moreover, parameters indicating high bone turnover variables were examined by regression analysis. P values less (alkaline phosphatase (AP), bone-specific alkaline phothan 0.05 were considered significant. sphatase (BAP), and osteocalcin (OC )) have been shown to be significantly reduced [4, 5, 13, 14] as well as significantly increased in the post-transplantation
Results
period [3, 6, 15] . These parameters have been evaluated either only during a short period of time after kidney transplantation (up to 6 months) [6, 15] or over a Biochemical parameters of all 129 patients are summarlonger period (up to 2 years) but with long intervals ized in Table 1. between. [1, 3, 5, 16 ] . Therefore, we prospectively evaluThere was a significant fall in serum creatinine ated metabolic bone parameters at short intervals up concentration from 166 mmol/l to 140 mmol/l and a to 2 years after kidney transplantation, focusing on rise in calcium and albumin-adjusted calcium from 2 graft function and vitamin D status.
to 3 months after kidney transplantation with a gradual normalization thereafter. The upper normal limit for serum calcium in our laboratory is 2.62 mmol/l and was chosen in order to categorize patients as hyper-
Subjects and methods
or normocalcaemic. At 3 months more than 50% of all patients were hypercalcaemic. Phosphorus increased . Mean time on haemodialysis prior to years after transplantation; 25 (OH )D increased transplantation was 67 months (range 7-240 months). All slightly but remained within the lower normal range; patients received prednisone (cumulative dose within 2 1,25 (OH ) 2 D3 (evaluated in 24 patients) also showed months after kidney transplantation 1000 mg, during the first a gradual rise, which remained in the normal range. year 4500 mg, and in the second year 3700 mg) and cyclospo-PTH did not fluctuate during the observation period. rin A. In 32 patients rejection episodes occuring during the PTH was positively correlated with the OC levels: r first month were treated with 500 mg i.v. prednisone/day for between 0.54 and 0.33, P<0.01 throughout the study 3 consecutive days. The cyclosporin A dose was adjusted to period (see Table 8 to graft function: group I, good renal function, Biochemical measurements: serum creatinine, calcium, creatinine∏132 mmol/l (n=64), and group II, impaired phosphate, alkaline phosphatase (AP) and albumin were renal function, creatinine >132 mmol/l (n=65). measured by standard techniques. Albumin corrected The serum creatinine cut off level of 132 mmol/l calcium was calculated according to Payne et al. [17] .
Immunoreactive parathormone (PTH ) was measured by a (1.5 mg/dl ) was chosen in order to recruit a subgroup two-site immunoradiometric assay (Nichols Allegro Irma of patients having stable graft function with creatinine PTH-kit) normal values510-50 pg/ml. Bone-specific alkaline levels less than the average of all patients.
phosphatase (BAP) was measured by immunoradiometric
The characteristics of these groups are summarized assay (Tandem-R-Ostase, Hybritech, San Diego, CA, USA). in Table 2 .
Normal values: 4 to 20 ng/ml. Osteocalcin (OC ) was deterBoth groups are similar in terms of age, time on mined by a radioimmunoassay measuring intact osteocalcin dialysis and 25(OH ) D status. Moreover, the calcium and no fragments(SOSCA TestB) (BGP) Brahms, Berlin, and phosphorus concentrations did not differ in the early The relevant biochemical bone parameters of group III function and could be stratified to group I, while the and IV are summarized in Table 6 .
other 16 patients still had impaired graft function.
There was no difference in creatinine, calcium and phos-
The biochemical parameters of group I and II are phorus levels between the two groups.
summarized in Table 3: AP, BAP and OC concentrations were not influenced by
The peak in serum calcium at 3 months was observed 25(OH )D levels (data not shown). PTH, however, was in both groups and calcium levels were slightly higher significantly higher in patients with low 25(OH )D levels and in group I. Moreover, there was a wide range in were negatively correlated (r=−0.49; P<0.001) ( Table 8 ). calcium levels between 1.16 and 3.45 mmol/l. A rise in AP and BAP between 3 and 5 months after Rtx was observed in both groups with normalization after 12 months. OC, however, was still above normal in Influence of graft function and 25(OH)D status on patients with impaired graft function even 2 years after PTH levels Rtx. Throughout the study period there was a positive correlation between serum creatinine and osteocalcin As demonstrated in Tables 1, 3 and 6, PTH concentrations from 5 up to 24 months after transplantation (r=0.35 were stable without further fluctuations during the study at 5 months and r=0.53 at 24 months; P<0.01).
period. PTH levels in a subgroup of patients (n= 35) with PTH was significantly higher in patients with good graft function and normal 25(OH ) D levels were even closer to normal (Table 7) . impaired graft function.
As expected, there was a positive correlation of PTH with serum creatinine (correlation coefficient between 0.51 and 0.42, P<0.001) ( Table 8) . No correlation was found between the cyclosporin A levels and cal-Influence of duration of haemodialysis cium, AP, BAP, or PTH levels.
We observed a positive correlation between the duration of haemodialysis and the PTH concentrations only 2 and 3 months after transplantation (Table 8) . Furthermore the OC concentra-
Influence of 25 (OH) D status on biochemical bone
tions were positively correlated with the duration of haemodiaparameters lysis 2 and 3 months after transplantation (P<0.01 and P<0.02 respectively). Duration of haemodialysis did not influence the We found a seasonal variation in 25(OH ) D concentrations, post-transplantation concentrations of calcium, AP or BAP. with a peak in August and a nadir in January ( Table 4) . Because we had to consider not only the time period after Rtx, but also the seasonal variation in vitamin D status, we subdivided the patients into two further goups: patients who had 25(OH ) D concentrations lower than the average of the Discussion corresponding month were considered as 'low 25(OH ) D group' (group III, n=63) and those who had 25(OH ) D concentrations higher than the average were considered as Our study clearly demonstrates a high bone turnover 'normal 25(OH ) D group'(group IV, n=66).
within the first 5 months after kidney transplantation The characteristics of both groups are summarized in irrespective of graft function, with a gradual normaliza- Table 5. tion thereafter. We observed a gradual rise from low When patients were stratified according to 25(OH )D status serum phosphorus concentrations up to 1 year after 2 months after transplantation, there was no difference in renal function between the two groups. kidney transplantation. The low levels of serum phos-phorus immediately after transplantation are due to decreased phosphate reabsorption (tubular defect) [19, 20] . Moreover, PTH is now able to exert its phosphaturic effect in the transplanted kidney. A phosphaturic action of steroids must also be considered, because an increase in serum phosphorus levels after reduction of steroid doses has been reported [21] .
In our study we observed a rise in total and albumin corrected serum calcium concentrations from 2 to 3 months after kidney transplantation (52% of all patients were hypercalcaemic at 3 months) with a wide range in calcium concentrations. A gradual fall was then observed and only 15% were still hypercalcaemic 24 months after transplantation. Several studies have demonstrated post-transplantation hypercalcaemia [8, 10, 11, 16 ] . Our findings are in agreement with those of Christensen et al. [12] , who saw a peak in serum calcium concentrations in 16.7% of patients more than 2 months after kidney transplantation. Cundy et al. [9] found hypercalcaemia in 36%, with a mean onset of five months after transplantation. They also found an association between the duration of haemodialysis and post-transplantation hypercalcaemia, but we could not confirm these findings.
Vezzoli et al. [11] demostrated elevated ionized calcium concentrations in 66% of their patients and among those more than half of them had normal PTH levels. Indeed, in our study we found a calcium peak irrespective of graft function and calcium levels were not correlated with PTH concentrations, suggesting a mechanism independent of PTH. Calcium was slightly higher in patients with good graft function and significantly lower PTH levels.The lower PTH levels may be due to negative feedback from the elevated calcium. Furthermore, resorption of extraskeletal calcifications may contribute to the hypercalcaemic state [22] . Two recent studies failed to find any hypercalcaemia after kidney transplantation [2, 6 ] , although Saha et al. [2] did not measure parameters between 15 days and 6 months after grafting and may have missed a relevant rise in calcium concentrations.
We observed a significant increase in the AP and BAP concentrations 2-5 months after transplantation with values back in the normal range only between 8 and 12 months after transplantation. Two recent studies have evaluated BAP and AP for a period of up to 6 months after transplantation and also found BAP increase with a peak at 3 months [15] and 6 months after transplantation [7] . Like Withold and associates [15] we found a good correlation between BAP and AP and also no correlation between PTH and BAP, again suggesting that PTH independent mechanisms contribute to the rise in those two parameters.. Bryer et al.
[23] demonstrated increased bone turnover in rats treated with cyclosporin A as evidenced by elevated osteocalcin levels and histomorphometric osteopenia compared to rats treated only with azathioprine. Stein et al. [24] found an increase in 1a-hydroxylase activity with significant elevations in serum 1,25 (OH) 2 D3 levels in rats and mice and Movsowitz et al. [25] found a high-turnover osteoporosis in rats with an increase of serum OC and 1,25 (OH) 2 after transplantation and explained this phenomenon by
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the effect of steroids on bone [13] . In our study, osteocalcin also increased significantly after transplantation, especially in those patients with Table 6 . Biochemical bone parameters after kidney transplantation according to 25(OH )D supply. Group III: patients (n=66) with normal 25(OH )D levels. Group IV: patients (n=63) with low 25(OH )D levels
Group
Months after renal transplantation 2  3  5  8  1 2  1 8  2 4  III  IV  III  IV  III  IV  III  IV  III  IV  III  IV  III [24] . (OH ) D status plays a major role in post-transplantaIn summary: hypercalcaemia is a common phenomtional hyperparathyroidism; almost all patients had very low 25 (OH ) D levels 2 months after transplanta-enon in the early period after kidney transplantation 
